Receptor and substrate interactions of clostridial neurotoxins
Different mechanisms of inhibition of nerve terminals by botulinum and snake presynaptic neurotoxins
Translocation of botulinum neurotoxin light chain protease by the heavy chain protein-conducting channel
Association of botulinum neurotoxins with synaptic vesicle protein complexes
Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxins
A novel function of botulinum toxin-associated proteins
Engineered toxins
Central effects of tetanus and botulinum neurotoxins
Immune recognition of BoNTs A and B
Disease-oriented approach to botulinum toxin use
Migraine prophylaxis with botulinum toxin A is associated with perception of headache
Treatment of focal dystonias with botulinum neurotoxin
Botulinum toxin for the management of adult patients with upper motor neuron syndrome
Botulinum toxin in the treatment of OAB, BPH, and IC
Gynecological indications for the use of botulinum toxin in women with chronic pelvic pain
Perioperative use of botulinum toxins
Intra-articular Botulinum Toxin Type A
Development of future indications for BOTOX®
Unique properties of botulinum toxins
Basic and clinical aspects of BOTOX® ☆
Dysport® ☆
NeuroBloc®/Myobloc® ☆
Xeomin is free from complexing proteins ☆
Discussion of unique properties of botulinum toxins ☆